Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 73.00
-0.90 (-1.22%)
Sep 11, 2025, 5:24 PM IDT
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 153.12 million as of September 12, 2025. Its market cap has increased by 17.29% in one year.
Market Cap
153.12M
Enterprise Value
205.67M
Revenue
-501.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
73.00
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 153.12M, an increase of 422.12%. That is a compound annual growth rate of 27.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 158.58M | 6.60% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | 93.74M | 338.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 76.30B |
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.36B |
| BrainsWay | 991.19M |
| SofWave Medical | 980.61M |
| Bait Bakfar | 979.07M |
| Novolog (Pharm-Up 1966) | 757.12M |
| Ilex Medical | 708.32M |